Jiang, Xiaojun <br/><br/>
The sum of gains and losses of genes encoding the protein tyrosine kinase targets predicts response to multi-kinase inhibitor treatment: Characterization, validation, and prognostic value.  [electronic resource] 

 -  Oncotarget  Sep 2015 
 - 26388-99 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.4557  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Algorithms<br/>Antineoplastic Agents--therapeutic use<br/>Biomarkers, Tumor--antagonists & inhibitors<br/>DNA Copy Number Variations<br/>Decision Support Techniques<br/>Disease-Free Survival<br/>Female<br/>Gene Amplification<br/>Gene Deletion<br/>Gene Expression Profiling<br/>Genetic Testing--methods<br/>Humans<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Molecular Targeted Therapy<br/>Neoplasms--drug therapy<br/>Patient Selection<br/>Precision Medicine<br/>Predictive Value of Tests<br/>Protein Kinase Inhibitors--therapeutic use<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Reproducibility of Results<br/>Risk Factors<br/>Signal Transduction<br/>Time Factors<br/>Treatment Outcome<br/>Young Adult